CLClinicLens

Surgery

The UroLume endoprosthesis and UroLume cripple syndrome: a systematic review and meta-analysis of pathophysiology, complications, surgical management, psycholog

The UroLume endoprosthesis (AMS/Endo-care), commercially available 1988-2007 and FDA-approved in 1996, was positioned as a permanent minimally invasive solution for recurrent bulbar urethral stricture and benign prostatic hyperplasia. Despite early procedural success, long-term d

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.